Cadherin 5 Antikörper (Alexa Fluor 647)

Produktnummer ABIN2657633

Dieses Anti-Cadherin 5-Antikörper ist ein Ratte Monoklonal-Antikörper zur Detektion von Cadherin 5 in WB, IHC, ELISA, IP, Neut, ICFC und CyTOF. Geeignet für Maus.

Kurzübersicht für Cadherin 5 Antikörper (Alexa Fluor 647) (ABIN2657633)

Target: Cadherin 5 (CDH5)

Reaktivität: Maus

Wirt: Ratte

Klonalität: Monoklonal

Konjugat: Dieser Cadherin 5 Antikörper ist konjugiert mit Alexa Fluor 647

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunoprecipitation (IP), Neutralization (Neut), Intracellular Flow Cytometry (ICFC), Cytometry by Time of Flight (CyTOF)

Klon: VECD1

Produktdetails anti-Cadherin 5 Antikörper (Alexa Fluor 647)

Aufreinigung: The antibody was purified by affinity chromatography, and conjugated with Alexa Fluor® 647 under optimal conditions.

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.5 mg/mL

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Protect from prolonged exposure to light. Do not freeze.

Lagerung: 4 °C

Informationen zur Lagerung: The antibody solution should be stored undiluted between 2°C and 8°C

Details zu Cadherin 5

Target: Cadherin 5 (CDH5)

Andere Bezeichnung: CD144

Hintergrund: CD144, also known as vascular endothelial-cadherin (VE-cadherin), is a 120 kD member of the type II Cadherin family. It is an endothelial specific hemophilic adhesion molecule involved in endothelial cell survival, migration, contact-dependent growth inhibition and homophilic adhesion. VE-cadherin is essential for maintaining the integrity of the endothelial barrier in vivo.

Pathways: Cell-Cell Junction Organization, Signaling Events mediated by VEGFR1 and VEGFR2